Tag: bowel cancer

  • Vitamin D: A Ray of Prevention in Colorectal Cancer

    Vitamin D: A Ray of Prevention in Colorectal Cancer

    Rickets is the archetypical disease of vitamin D deficiency in children. It was ubiquitous in the industrialised cities of the UK. Theobald Palm finished studying medicine at the University of Edinburgh in the 1800s. The son of Scottish Presbyterian missionaries, he was born in Ceylon, now Sir Lanka. Following medical school, began medical missionary work in Japan. There he noticed that rickets was virtually absent. Had Palm remained a medical missionary, nothing might have transpired. But he returned to the UK and there he noted an epidemic of rickets in large towns that had limited sunlight exposure. As with many groundbreaking medical discoveries, for many years, Palm’s observations were largely ignored. Ultimately, following Palm’s shrewd observations, it was recognised that the production of vitamin D in the body was contingent on exposure to UVB.

    What is Vitamin D?

    Perhaps surprisingly, vitamin D is not a vitamin at all. It is actually a prohormone involved in the tight regulation of calcium and phosphate levels. Hence, it is vital for healthy bones, effective muscle contraction, immune function and other important cellular functions.

    So vitamin D has long been celebrated for its role in bone health. Yet its influence on broader health outcomes is garnering increasing attention. This is particularly the case in preventing early-onset colorectal cancer (CRC). Recent research leveraging the extensive UK Biobank data provided compelling insights into how vitamin D might play a pivotal role in warding off CRC, especially among adults under 50. The UK biobank is a huge repository of biomedical data that can be accessed by medical researchers worldwide.

    A Closer Look at the Research

    The study in question delved into the health records of 236,382 Korean adults. It tracked a range of health metrics, including serum 25-hydroxyvitamin D [25(OH)D] levels. The follow-up period averaged 6.5 years. In this time the researchers discovered that higher levels of vitamin D were associated with significantly reduced risks of developing colorectal cancer. These were findings that held strong even after adjusting for numerous potential confounders.

    Vitamin D and Its Protective Mechanisms

    What’s particularly intriguing about this study is its implications for both young and older adults. For those under 50, maintaining higher levels of vitamin D was linked with a nearly 60% reduction in CRC risk. This protective effect, although slightly attenuated, was also evident in the older cohort. Hence, the study suggests that vitamin D’s benefits span age groups.

    The biological underpinnings of vitamin D’s protective effects relate to its regulatory role of our DNA. Vitamin D helps orchestrate the expression of several genes. This includes those involved in cell growth and repair. Such mechanisms are vital for cancer prevention. Essentially, vitamin D acts much like a fastidious manager within a complex system. It ensures that everything runs smoothly and efficiently. Importantly, it also shuts down potential problems before they escalate.

    Practical Implications and Lifestyle Integration

    Given the association between vitamin D levels and reduced CRC risk, particularly among younger adults, there is a strong case for assessing your vitamin D status. This is especially the case for those with a family history of colorectal cancer. Here’s how you can incorporate this knowledge into a proactive health strategy:

    1. Regular Screening: Consider regular checks of your vitamin D levels as part of your routine health assessments. This is especially pertinent during the darker months. It’s also particularly important if your lifestyle limits sun exposure.
    2. Mindful Supplementation: If your vitamin D levels are found to be lacking, supplementation could be a key strategy. It’s a simple, safe way to potentially reduce your risk of serious health issues like colorectal cancer.
    3. Dietary Sources: Sunlight is the primary source of vitamin D. However, incorporating vitamin D-rich foods like fatty fish, fortified dairy products, and certain mushrooms can also help boost your levels.
    4. Understanding Your Genetics: The study highlighted that genetic factors might influence how vitamin D impacts us. Engaging with genetic screening could provide personalised insights, tailoring your approach to supplementation.

    A Final Thought

    We have to navigate a plethora of dietary advice and health strategies. Understanding the nuanced role of nutrients like vitamin D in disease prevention is crucial. This isn’t just about taking a supplement. It’s also about integrating a scientifically backed approach into your daily routine for long-term health benefits.

    Theobald Palm extolled the virtues not only of sunlight. He urged the use of open spaces, especially playgrounds for children. This is something we should take to heart. A vitamin D supplement may be beneficial. But the benefits of safe sun exposure, movement and nature compound to maximise health benefits. 

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • Unmasking Early Signs of Colorectal Cancer in Younger Adults: Key Insights from Recent Study

    Unmasking Early Signs of Colorectal Cancer in Younger Adults: Key Insights from Recent Study

    There has been a concerning rise in early-onset colorectal cancer among individuals under 50. A recent study by Dr. Cassandra D. L. Fritz and colleagues at Washington University in St. Louis has brought critical insights that could aid in early detection and timely diagnosis. This information is not just data; it’s a potential lifesaver.

    The Rise of Early-Onset CRC

    Colorectal cancer is traditionally associated with older age. However, it is alarmingly increasing among the younger population. Indeed, we have colleagues and relatives under 40 who have been afflicted. This shift underscores the need for heightened awareness and vigilance, especially in spotting early signs.

    The Study: A Closer Look

    The researchers conducted an extensive study involving 5,075 individuals with early-onset colorectal, using data from U.S. commercial insurance beneficiaries. The focus was on identifying ‘red-flag’ signs and symptoms that occurred from three months to two years before the diagnosis.

    Key Findings: Red Flags in the Spotlight

    The study identified four significant red-flag symptoms and signs associated with an increased risk of early-onset colorectal cancer:

    • Abdominal Pain
    • Rectal Bleeding
    • Diarrhoea
    • Iron Deficiency Anaemia

    The odds ratios (ORs) for these symptoms ranged from 1.34 to 5.13, indicating a substantial link to early-onset CRC.

    Risk Amplification with Multiple Symptoms

    The presence of one, two, or at least three of these symptoms was associated with progressively higher risks:

    • 1 symptom: 1.94-fold increase
    • 2 symptoms: 3.59-fold increase
    • 3 or more symptoms: 6.52-fold increase

    Age and Cancer Type: Specific Considerations

    Interestingly, these associations were even stronger in younger individuals and those with rectal cancer.

    Diagnostic Timelines: A Crucial Element

    About 19.3% of patients had their first symptom between three months and two years before diagnosis, with a median diagnostic interval of 8.7 months. Approximately 49.3% exhibited their first symptom within three months of diagnosis, highlighting the critical window for early detection.

    A Call for Proactive Health Management

    This study underscores the importance of early recognition of these red-flag symptoms. Early detection is key in battling CRC, especially in its early onset. Understanding these warning signs and acting promptly can make a significant difference in outcomes. If you or someone you know experiences these symptoms, at any age, please seek medical evaluation. Your health and well-being are paramount. 

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • The qFIT test – the new detection test tackling Bowel Cancer

    The qFIT test – the new detection test tackling Bowel Cancer

    The qFIT test checks for bleeding from the gastrointestinal tract. Bowel cancer is the 4th most common cancer and the 2nd most common cause of death in the UK. This makes it a strong target for new and innovative detection technologies. Early detection is vital for potential intervention and cure with any disease. However, we still see the majority of cases not being diagnosed early due to a lack of knowledge or understanding of symptoms.

    Bowel cancer is an all-inclusive term for cancer in the large bowel or colon and the back passage or the rectum. Abnormal cells start to divide and grow in an uncontrollable way which can lead to the possibility of unwanted cells spreading to other parts of the body.

    To help minimise this progression, a simple test to help diagnose possible symptoms leading to potential intervention is the most successful tool we have in reducing these statistics. Most, but by no means all bowel cancers start off as polyps. The majority of polyps remain small and harmless. Some, however, develop into malignant cancers that can invade into the wall of the colon. The progression from harmless polyp to cancer can occur over 10 or so years. So, screening can provide an excellent tool in our armoury against cancer in this 10-year window of opportunity.

    The new qFIT (Quantitative Faecal Immunochemical Test) testing package is a tool used for primary screening for patients without symptoms such as bleeding or change in bowel habit. It is also sometimes as a management guide for patients with symptoms. The simple stool sample test does not look for cancerous cells specifically. However, it detects certain antibodies and blood in the stool that could develop into cancerous symptoms. This is used as the first line of detection to allow for further testing if needed to identify the cause. The next line of testing is usually direct visualisation of the colon with a colonoscopy.

    This new test, is now offered here at Coyne Medical. We use it as part of our health screenings and opportunistically in GP appointments for patients who are suitable. FIT Testing has been shown to detect twice as many cancers and four times as many advanced polyps as the previous test, making it the most effective point of call for early detection.

    How The Test Is Carried Out

    Fit testing is carried out on a small amount of stool. We give you a special container for the sample and detailed instructions on how to do the test. You obtain the stool sample from stool passed into the disposable container we provide you with. The stool should not come into contact with the toilet water. The qFIT test requires only one stool sample and does not need any medications to be stopped. In addition, no alterations to diet are needed. When you have done the sample it can be mailed back to the laboratory. The process the results as soon as they receive the sample. It’s important to send it back to the lab as soon as possible. This is because delayed processing of the sample has been associated with lower detection of adenomas.

    Be Symptom Aware

    Whether or not you are planning to have a qFIT test done. It is very important to be aware of the symptoms of bowel cancer. These include:

    • Tummy pain
    • Change in bowel habit
    • Unintentional weight loss
    • Bleeding from the back passage
    • Bloating of the tummy
    • Nausea or vomiting
    • Fatigue, lack of energy and shortness of breath on exertion

    For people between the ages of 40-74 years, we recommend having a screening annually. In the UK and some other countries, the testing is less frequent and one study in the Netherlands did show that screening every three years resulted in the same population positivity rate. However, if you have any relevant family history, a simple concern or would like to find out more information about symptoms or the test itself, please contact us on 020 7731 3077.

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.